by subject – Page 7 – Retraction Watch

‘We should have followed up’: Lancet journal retracts article on hearing aids and dementia after prodding

When Jure Mur, a postdoc at the University of Edinburgh in Scotland, realized the replication of a published study he was working on as a “sanity check” wasn’t producing matching results, his first reaction was “annoyance,” he said.

He assumed the mistake was his own, and he’d have to thoroughly check his work to find it. “Only after double- and triple-checking my code did I start suspecting an error in the original paper,” Mur told Retraction Watch.

Mur emailed the authors of the article several times, but they never responded to him, he said. He next contacted the editors of The Lancet Public Health, which had published the original paper, “Association between hearing aid use and all-cause and cause-specific dementia: an analysis of the UK Biobank cohort,” in April 2023.

A closer look at the ‘chocolate with high cocoa content’ hoax

We are pleased to present an excerpt from The Predatory Paradox: Ethics, Politics, and Practices in Contemporary Scholarly Publishing by Amy Koerber, Jesse C. Starkey, Karin Ardon-Dryer, R. Glenn Cummins, Lyombe Eko, and Kerk F. Kee, published by Open Book Publishers, October 2023.

In 2015, Johannes Bohannon, along with three coauthors, published an article titled ‘Chocolate with High Cocoa Content as a Weight Loss Accelerator’ in the International Archives of Medicine. The article reported results from a study that divided participants into three groups, with a different diet assigned to each group, and concluded that ‘Subjects of the chocolate intervention group experienced the easiest and most successful weight loss’ (p. 1).

In a personal account published later, journalist John Bohannon described the article as an intentional hoax that he and his coauthors had carried out in response to a request from a German film crew who was making a documentary on the ‘junk-science diet industry.’ To implement the hoax, Bohannon and his coauthors created an ‘Institute of Diet and Health’ that existed only as a website, and he assumed the name ‘Johannes Bohannon’ as lead author of the study. As he explained, the research reported in the article was actually conducted, but it was “terrible science,” including major flaws that would have been detected if the article had undergone a legitimate peer-review process.

Bohannon and his colleagues’ ‘Chocolate with High Cocoa Content’ article was retracted shortly after it was published, and the editors of International Archives of Medicine published a retraction notice dated 10 June 2015 (Editorial Office 2015). The editors’ decision to retract this article ostensibly served to correct the scientific record and prevent the erroneous data reported in the published study from being circulated in subsequent literature. This manner of correcting the scientific record is an important purpose of retractions, as defined by the Committee on Publication Ethics (COPE):

Psychology professor earns retractions after publishing with ‘repeat offenders’

A psychologist in Australia has earned a pair of retractions after publishing several papers with international coauthors suspected of authorship fraud, Retraction Watch has learned.

Kelly-Ann Allen, an associate professor at Monash University, in Clayton, and editor-in-chief of two psychology journals, declined to comment for this article.

The retraction notices, both in Frontiers journals, cite an investigation by the publisher confirming “a serious breach of our authorship policies and of publication ethics.”

Journal retracts 31 papers, bans authors and reviewers after losing its impact factor

A journal that lost its impact factor and spot in a major index this year has made good on a promise to retract dozens of papers with “compromised” peer review.

Genetika, a publication of the Serbian Genetics Society, did not receive an updated impact factor this year after Clarivate, the company behind the closely-watched but controversial metric, identified signs of citation stacking, a practice in which authors or journals seem to trade citations. Clarivate also dropped Genetika from its Web of Science index for failing to meet editorial quality criteria.

Clarivate’s actions followed a blog post by scientific sleuth Elisabeth Bik about what she called the “Iranian Plant Paper Mill, which included 31 papers published in Genetika.

‘A bit of a surprise’: Transportation officials pushed to retract archaeology article on work they funded

After bankrolling archeological work on a prehistoric site discovered during construction, a state department of transportation has successfully lobbied to retract an article about the researchers’ findings officials said were “published prematurely.”

The whole process was “a bit of a surprise” for the paper’s co-authors, said Logan Miller, one of the authors and an archeology professor at Illinois State University. He and lead author David Leslie both told Retraction Watch they stand by the article’s findings, but declined to comment further about the retraction.

Their research began in 2019, when the Connecticut Department of Transportation (CTDOT) wanted to replace a bridge in the town of Avon. When construction workers started digging into the old bridge’s foundations, however, they discovered thousands of ancient objects from the Paleoindians, the earliest known people to live in New England. CTDOT temporarily halted the work and contracted an archaeology firm to excavate the site.

Publisher pulls books about philosophers Žižek and Venn over citation issues

A large U.S. university press has stopped selling two scholarly books about the philosophers Slavoj Žižek and John Venn due to problems with how the authors cited – or didn’t cite – source material.

In both cases, the University of Chicago Press stated on its website that the titles, released in 2023 and 2022, respectively, were “no longer available for sale.” But only “John Venn: A Life in Logic” by Lukas M. Verburgt was “retracted,” according to the publisher.

The author of the other publication – “How Slavoj Became Žižek: The Digital Making of a Public Intellectual” – told us he had been afforded a chance to fix his mistakes. These included “several insufficient, missing, or erroneous citations of source material upon which the author builds his argument,” the University of Chicago Press stated.

“The publisher has given me the opportunity to correct the book and resubmit it for review,” said Eliran Bar-El, a sociologist at the University of York, in England. “In light of it being an ongoing process, I cannot provide further details until there is a review outcome, which will be reflected appropriately in my publication list. At this time, I would like to genuinely thank the observant readers who have brought this to my attention.”

Verburgt, whose work contains “numerous instances of insufficiently cited source material,” does not appear to have been quite as lucky.

‘Super Size Me’: What happened when marketing researchers ordered a double retraction?

A year after the authors of two papers contacted the marketing journal where they had been published requesting retraction, the journal has pulled one, but decided to issue a correction for the other.

In April, we reported that the Journal of Consumer Research was investigating “Super Size Me: Product Size as a Signal of Status,” originally published in 2012, and “Dynamics of Communicator and Audience Power: The Persuasiveness of Competence versus Warmth,” published in 2016.

The authors had asked to retract the papers in October 2022 after other researchers found inconsistencies in the statistical calculations of the “Super Size Me” paper and could not replicate the results. The article had been cited nearly 200 times, according to Clarivate’s Web of Science. It attracted attention from The New York Times and NPR, among other outlets, which linked the findings to the rise in obesity in the United States. An analyst also found issues in the 2016 paper, which has been cited 71 times.

When we published our previous story, Carolyn Yoon, the chair of the journal’s policy board and a professor of management and marketing at the University of Michigan, Ann Arbor’s Stephen M. Ross School of Business, told us the board was still waiting on a report from the special committee investigating the matter. “We hope to have a decision by the end of this month,” she said in April 2023.

Research integrity during the COVID-19 pandemic: A book excerpt

We are pleased to present an excerpt from Thinking About Science: Good Science, Bad Science, and How to Make It Better by Ferric C. Fang and Arturo Casadevall, published by ASM Press/Wiley, October 2023.

Amidst the COVID-19 calamity, one can argue that science is one of the few aspects of the human response that has worked relatively well. However, despite the many advances in preventing and treating COVID-19, there have also been missteps as the world has scrambled to respond to a deadly new pathogen. It has been humbling for the U.S. to lead large high-income countries in per capita deaths from COVID-19 even with its wealth and scientific expertise. We are all too aware of the needless illnesses and deaths that have resulted from misguided political leadership, inadequate preparation, delayed responses, fragile supply chains, health disparities, and vaccine hesitancy. But we will not dwell on these issues here. Rather, we would like to review the COVID-19 pandemic through the prism of the 3R’s of research integrity: rigor, reproducibility, and responsibility. These form the fundamental pillars of the foundation of science. It is appropriate that we devote more attention to the foibles than to the successes so that we can learn from the mistakes and missed opportunities. What could have been done better? What needs to improve?

Publisher looking into COVID vaccine paper with ‘serious flaws’

A controversial paper on the safety and immunogenicity of an Iran-made COVID-19 vaccine is being investigated by the U.S.-based publisher Wiley, Retraction Watch has learned.

Iran reportedly has already administered 3 million doses of the vaccine, dubbed Noora, which the country licensed for emergency use last year.

The paper describes the vaccine’s first test in humans, marking the only time results from the clinical development of the homegrown shot have been reported in international journals.

“Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial” was published in 2022 in the Journal of Medical Virology, an achievement highlighted in Iranian news media. One report said the study showed a dose of 80 micrograms of the vaccine was “safe” and provided “adequate immunity in adults.”

Article defending private-equity involvement in autism services retracted

An article that proposed potential benefits of private equity firms investing in autism service providers has been removed from the journal in which it was published.

The article, “Private equity investment: Friend or foe to applied behavior analysis?” was originally published in the International Electronic Journal of Elementary Education as part of a January 2023 special issue devoted to applied behavior analysis (ABA) for autism.

ABA is the most widely used therapy for autism, and companies that provide it have faced a flood of interest from private equity firms in the past decade.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: